These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19954644)

  • 1. [Effects of SHIP gene mutation on cell cycle related proteins and phosphorylated Akt in K562 cells].
    Yang L; Luo JM; Liu XJ; Wen SP; Yang JC; Zhang JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Aug; 30(8):548-52. PubMed ID: 19954644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect of lentiviral vector-mediated SHIP gene transfection on proliferation of leukemia K562 cells and PI3K/Akt pathway regulation].
    Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L
    Ai Zheng; 2009 Apr; 28(4):366-72. PubMed ID: 19622295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanism for SHIP gene to induce the apoptosis of human leukemia cell line K562.].
    Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L; Yang JC
    Sheng Li Xue Bao; 2009 Apr; 61(2):146-54. PubMed ID: 19377826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of SHIP mutation on invasion and migration of K562 leukemia cells].
    Liu XJ; Yang L; Wen SP; Yao L; Yang JC; Luo JM
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):38-42. PubMed ID: 22575191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutation analysis of SHIP gene in acute leukemia].
    Luo JM; Liu ZL; Hao HL; Wang FX; Dong ZR; Ryuzo O
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):385-8. PubMed ID: 15355687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
    Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
    Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and SHIP gene expression in K562 cells].
    Jia ZQ; Wei YT; Li AM; Cheng ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):916-9. PubMed ID: 23998585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of bortezomib combined with 5-azacytidine on the apoptosis of K562 cells and expression of SHIP mRNA].
    Jia ZQ; Wei YT; Wei YL; Su W; Yu CX; Tao J; Rong HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1291-4. PubMed ID: 25338575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
    Zhu X; Kwon CH; Schlosshauer PW; Ellenson LH; Baker SJ
    Cancer Res; 2001 Jun; 61(11):4569-75. PubMed ID: 11389092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of SHIP gene in acute leukemia.
    Luo JM; Liu ZL; Hao HL; Wang FX; Dong ZR; Ohno R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):420-6. PubMed ID: 15363123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of wild type PTEN gene on proliferation, apoptosis and the influence on apoptosis key factor Bcl-2 and Caspase family on K562 cells].
    Cheng ZY; Liang WT; Niu ZY; Xue F; Yao L; Pan L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):679-83. PubMed ID: 19764572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathway.
    Cheng ZY; Guo XL; Yang XY; Niu ZY; Li SH; Wang SY; Chen H; Pan L
    J Exp Clin Cancer Res; 2008 Dec; 27(1):87. PubMed ID: 19115995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
    Wang W; DU Y; Lin GQ; Li NN; Sun BZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1).
    Turturro F; Frist AY; Arnold MD; Seth P; Pulford K
    Oncogene; 2001 Jul; 20(33):4466-75. PubMed ID: 11494142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
    Schmidt M; Fan Z
    Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
    Jiang D; Wang X; Liu X; Li F
    Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [P21(WAF1) inhibits the growth of leukemia cell line K562 and decreases its sensitivity to Vp16].
    Yang H; Wang S; Yin H
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):19-22. PubMed ID: 12015083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.